Kinnevik AB (publ)
- SEC CIK
- 0001766574
- Latest filing
- Nov 4, 2025
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Kinnevik AB (publ), including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q3 2025 holdings
- Shares (Q3 2025)
- 13,434,171
- Value
- $65.6M
- % of portfolio
- 100.0%
- Quarters held
- 12
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 13,434,171 | $65.6M | 100.0% | 00.0% | Unchanged | Holders |
| Q2 2025 | 13,434,171 | $68.0M | 100.0% | 00.0% | Unchanged | Holders |
| Q1 2025 | 13,434,171 | $71.1M | 100.0% | +1,528,503+12.8% | Added | Holders |
| Q4 2024 | 11,905,668 | $80.5M | 100.0% | 00.0% | Unchanged | Holders |
| Q3 2024 | 11,905,668 | $78.5M | 100.0% | 00.0% | Unchanged | Holders |
| Q2 2024 | 11,905,668 | $89.3M | 100.0% | +1,500,000+14.4% | Added | Holders |
| Q1 2024 | 10,405,668 | $103.7M | 100.0% | 00.0% | Unchanged | Holders |
| Q4 2023 | 10,405,668 | $102.6M | 100.0% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,405,668 | $79.6M | 100.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,405,668 | $77.7M | 100.0% | +2,752,607+36.0% | Added | Holders |
| Q1 2023 | 7,653,061 | $51.0M | 68.5% | 00.0% | Unchanged | Holders |
| Q4 2022 | 7,653,061 | $59.0M | 33.3% | +7,653,061 | New | Holders |